Hematologic Malignancies
News
Do Post-Transplant Tests Show Recurring Multiple Myeloma?
Researchers question the meaning of oligoclonal patterns in patients who have received stem cell therapy for multiple myeloma.
News
FDA Approves New Leukemia Treatments
Three new drugs have been approved by the FDA for patients with acute leukemia types and show promising remission rates.
News
FDA approves first gene therapy – tisagenlecleucel for ALL
“New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to...
Patient Care
The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA
The Hematopathology Molecular Genetics subcommittee presents recommendations for molecular diagnostic testing in acute myeloid leukemia,...
Article
Which Acute Myeloid Leukemia Patients are Good Immunotherapy Candidates?
Researchers assess how patients’ immune systems respond to a flu vaccine after chemotherapy to determine the likelihood of positive immunotherapy...
Conference Coverage
Evaluation of Fitness, Metabolism, and Quality of Life During Hematopoietic Stem Cell Transplant
Conference Coverage
Characterization of Hematology Consults for Complete Blood Count Abnormalities: A Single Center Experience in the Era of Electronic Consultation
Abstract 2: 2017 AVAHO Meeting
News
Less lenalidomide may be more in frail elderly multiple myeloma patients
Starting patients on a reduced dose and increasing it gradually while monitoring carefully for adverse events, meant patients did not have to stop...
Conference Coverage
Four drugs better than three for myeloma induction
MADRID – Adding the proteasome inhibitor carfilzomib to induction regimens delivered quicker and deeper remissions.
Conference Coverage
Avelumab induces response in Hodgkin lymphoma after failed allo-SCT
LUGANO, SWITZERLAND – The immune checkpoint inhibitor avelumab showed efficacy against classical Hodgkin lymphoma among patients with disease...